Specialty Chemicals
Key highlights
- Indian Specialty Chemicals sector revenue growth is expected at approximately 6–7% in FY27, with domestic demand supporting 7–8% growth while export recovery remains contingent on normalization in West Asia logistics and global procurement.
- Sector operating margins are expected to decline to approximately 14–14.5% in FY27 from around 16% in FY26, reflecting crude-linked feedstock inflation, freight volatility and restrained pricing power.
- Product differentiation, regulatory approvals, customer-specific formulation capability and application engineering are the principal determinants of sustainable pricing power; companies with commodity-derived portfolios remain more exposed to Chinese imports.
- Prasol Chemicals, Tatva Chintan Pharma Chem, Bhansali Engineering Polymers, Rossari Biotech and Vidhi Specialty Food Ingredients reported strong FY27 revenue growth, although margin quality varies materially across companies.
- Capacity additions remain focused on import substitution, backward integration, higher-value derivatives, battery chemicals, semiconductor chemicals, construction chemicals, water treatment and personal-care ingredients.
- Balance-sheet quality is generally favourable across the selected companies, though working-capital intensity has increased for several players due to inventory stocking, higher receivables, freight disruption and export-led supply-chain uncertainty.
powered by IRIS
Unlock full access to this sectoral analysis with in-depth insights, comprehensive data, and exclusive reports.


